Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals
Authors
Keywords
-
Journal
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
Volume 39, Issue 9, Pages 1832-1841
Publisher
Wiley
Online
2015-08-11
DOI
10.1111/acer.12828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat
- (2015) Terril L. Verplaetse et al. PSYCHOPHARMACOLOGY
- The α2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats
- (2014) Dennis D. Rasmussen et al. ALCOHOL
- Combining theα1-Adrenergic Receptor Antagonist, Prazosin, with theβ-Adrenergic Receptor Antagonist, Propranolol, Reduces Alcohol Drinking More Effectively Than Either Drug Alone
- (2014) Dennis D. Rasmussen et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The Dopamineβ-Hydroxylase Inhibitor, Nepicastat, Reduces Different Alcohol-Related Behaviors in Rats
- (2014) Giancarlo Colombo et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use
- (2014) Mary J. Skelly et al. Brain and Behavior
- Prazosin Reduces Alcohol Drinking Throughout Prolonged Treatment and Blocks the Initiation of Drinking in Rats Selectively Bred for High Alcohol Intake
- (2013) Janice C. Froehlich et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The α1-Adrenergic Receptor Antagonist, Doxazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats
- (2012) Meghan L. O'Neil et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
- (2012) Karl Mann et al. BIOLOGICAL PSYCHIATRY
- Alcohol Consumption Induces Endogenous Opioid Release in the Human Orbitofrontal Cortex and Nucleus Accumbens
- (2012) J. M. Mitchell et al. Science Translational Medicine
- Prazosin Effects on Stress- and Cue-Induced Craving and Stress Response in Alcohol-Dependent Individuals: Preliminary Findings
- (2011) Helen C. Fox et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Effects of Prazosin, an α1-Adrenergic Receptor Antagonist, on the Seeking and Intake of Alcohol and Sucrose in Alcohol-Preferring (P) Rats
- (2011) Terril L. Verplaetse et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats
- (2011) A. D. Lê et al. PSYCHOPHARMACOLOGY
- A Pilot Trial of the Alpha-1 Adrenergic Antagonist, Prazosin, for Alcohol Dependence
- (2009) Tracy L. Simpson et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- α1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol
- (2008) Brendan M. Walker et al. ALCOHOL
- The α1-Adrenergic Receptor Antagonist, Prazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats
- (2008) Dennis D. Rasmussen et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- A Role for Brain Stress Systems in Addiction
- (2008) George F. Koob NEURON
- Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology
- (2008) N. D Volkow et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started